Our company not only brings the "ultra-low adsorption", "TC enhancement" and other high-quality technology and products that are well recognized in the industry, but also brings the leading UV light penetration plate, which allows 80% of the 260nm/280nm wavelength UV light to pass through its flat-bottom interface. It can allow 80% of UV light of 260nm/280nm wavelength to pass through its flat-bottomed interface, which can be utilized to quantify the content and purity of DNA and proteins.

The 3rd BIONNOVA Western Innovation Forum

2024-08-02



The 3rd BIONNOVA Western Innovation Forum will combine the breakthrough flashpoints of the biopharmaceutical industry throughout the year of 2023, aiming at the breakthroughs in various fields, focusing on the innovative and improved drugs of chemical drugs, antibodies of biopharmaceuticals, cellular and gene therapies, nucleic acids, extended peptide drugs, and coupled drugs such as ADC, PDC, etc., and focusing on the research and development, clinic, CMC production process, innovation and cooperation, and roadshow of investment and financing projects. We will bring 15 sub-forums to share the latest industry news, forward-looking insights and breakthroughs, creating the most influential industry event in the western region!


As an exhibitor, our company is honored to communicate and learn from outstanding enterprises and institutions and scientific research leaders in the industry, and participate in the sharing and discussion of academic frontiers and related products.


Conference site




Our company not only brings the "ultra-low adsorption", "TC enhancement" and other high-quality technology and products that are well recognized in the industry, but also brings the leading UV light penetration plate, which allows 80% of the 260nm/280nm wavelength UV light to pass through its flat-bottom interface. It can allow 80% of UV light of 260nm/280nm wavelength to pass through its flat-bottomed interface, which can be utilized to quantify the content and purity of DNA and proteins.


Our Booth





Share:

Subscribe to our current affairs communication